via UCL
Scientists have discovered a critical part of the body’s immune system with potentially major implications for the treatment of some of the most devastating diseases affecting humans.
Professor Graham Lord, from The University of Manchester, led the study, which could translate into treatments for autoimmune diseases including Cancer, Diabetes, Multiple Sclerosis and Crohn’s Disease within a few years.
It is published in The Journal of Clinical Investigation today.
The discovery of the molecular pathway regulated by a tiny molecule – known as microRNA-142 – is a major advance in our understanding of the immune system.
The 10-year-study found that microRNA-142 controls Regulatory T cells, which modulate the immune system and prevent autoimmune disease. It is, they found, the most highly expressed regulator in the immune system.
Autoimmune diseases often target people in the prime of their life creating a significant socio-economic burden on them. Sometimes, the effect can be devastating, causing terrible hardship and suffering. But these findings represent a significant step forward in the understanding of the immune system and we believe many people worldwide may benefit
Professor Graham Lord
And according to Professor Lord, the discovery could be translated into a viable drug treatment within a few years.
He said: “Autoimmune diseases often target people in the prime of their life creating a significant socio-economic burden on them. Sometimes, the effect can be devastating, causing terrible hardship and suffering.
“But these findings represent a significant step forward in the understanding of the immune system and we believe many people worldwide may benefit.”
If the activity of Regulatory T cells is too low, this can cause other immune cells to attack our own body tissues. If these Regulatory T cells are too active, this leads to suppression of immune responses and can allow cancers to evade the immune system.
So being able to control them is a major step forward in our ability to control- and harness – the therapeutic power of the immune system.
Professor Richard Jenner from UCL, who led the computational side of the project, said that: “We were able to trace the molecular fingerprints of this molecule across other genes to determine how it acted as such a critical regulator.”
Professor Lord, now Vice President and Dean of the Faculty of Biology, Medicine and Health at The University of Manchester, added: “Scientists over the past decade or so have developed therapies which are able to modulate different pathways of the immune system. We hope that this new discovery will lead to the development of new ways to treat autoimmunity, infectious diseases and cancer and we are incredibly excited about where this may lead.”
The Latest on: Autoimmune diseases
via Google News
The Latest on: Autoimmune diseases
- Amgen to Acquire ChemoCentryx for $3.7B, Bolstering Autoimmune Portfolioon August 5, 2022 at 7:02 am
Amgen has agreed to acquire ChemoCentryx for approximately $3.7 billion, the companies said today, in a deal that expands the buyer’s autoimmune portfolio with an approved drug and two clinical phase ...
- Amgen’s $3.7B ChemoCentryx acquisition adds a new piece to autoimmune strategyon August 4, 2022 at 6:14 pm
Amgen’s drug portfolio boasts several biologic drugs that are blockbuster sellers. In acquiring ChemoCentryx for $3.7 billion, the pharmaceutical giant gains a company entirely focused on developing ...
- What You Need to Know About This Rare Chronic Autoimmune Diseaseon August 4, 2022 at 8:00 am
IgA Nephropathy Awareness - 130,000-150,000 people in the United States suffer from this disease which leaves patients and their families feeling isolated and unsupported ...
- Georgia teen uses dance to cope with vision-altering autoimmune disorderon August 3, 2022 at 2:31 pm
Kimora Barker is a lot like any other 16-year-old, only the Morrow, Georgia, high schooler has a lot more doctor's appointments than her friends. She has grown up with an autoimmune disease that is ...
- Possible Link Between COVID-19 Vaccination and Autoimmune Disorders: Investigation by NCKU Researcherson August 2, 2022 at 10:42 pm
When the body's immune system turns on itself and attacks the body's healthy cells and organs, we develop autoimmune disorders. A rare entrant in the list of autoimmune disorders is acquired ...
- ADAR1 mutation sets off biochemical pathways that produce an organ-damaging autoimmune responseon August 2, 2022 at 2:03 pm
A new study shows how mutation of the ADAR1 gene sets off biochemical pathways that produce an autoimmune response that harms the developing brain and other areas of the body.
- Nanobody has potential to treat Parkinson's diseaseon August 2, 2022 at 5:00 am
Researchers from Johns Hopkins create a nanobody capable of penetrating brain cells and preventing misshapen proteins from spreading, halting the progression of neurocognitive diseases ...
- Dr. Yasmin Mohseni Announces Groundbreaking Treatment for Autoimmune Diseases and Solid Organ Transplantson August 1, 2022 at 10:23 am
Dr. Yasmin Mohseni, an immunologist at USC's Keck School of Medicine who specializes in research and clinical translation of immunotherapeutics, recently announced that companies are pursuing ...
- Zenas BioPharma gets Chinese approval for thyroid eye disease treatment studyon August 1, 2022 at 2:49 am
Zenas BioPharma has received approval from the NMPA in China to start a phase 1/2 clinical study of ZB001 to treat thyroid eye disease.
- Woman describes how she was 'humiliated' at a Walgreens as autoimmune patients become collateral damage in the US abortion crackdownon July 31, 2022 at 5:57 am
Methotrexate, a drug used to treat arthritis, lupus, IBD, and more, is being restricted across the US because it can cause abortions.
via Bing News
